Last updated: April 3, 2025
Sponsor: McNeel Eye Center
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Eye Disease
Vision Loss
Treatment
Crosslinking using UV light of two different fluence rates
Clinical Study ID
NCT02921009
MEC CxL Transepithelial
Ages 15-50 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Males or females between the ages of 15 and 50 with keratoconus diagnosedtopographically with or without other corneal ectatic disease.
Exclusion
Exclusion Criteria:
- Prior corneal transplantation, pregnancy, inability or unwillingness to adhere tofollow up protocol.
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Crosslinking using UV light of two different fluence rates
Phase:
Study Start date:
September 01, 2016
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
McNeel Eye Center
Boise, Idaho 83713
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.